ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,17
-0,69%
Dow Jones
40 211,72
0,00%
DAX
18 507,11
-0,50%
Brent Oil
82,935
-1,67%
Bitcoin
64 047,17
-1,24%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Italie
  5. BIT
  6. Abitare In Spa (ABT)

  7. Abitare In Spa (ABT) Actualités

ABT

Abitare In (ABT)

Abitare In Spa
De:
Trier par:
 Showing the most relevant articles for your search:BIT:ABT
DateHeureSourceTitreSymboleSociété
21/07/200915h30PR Newswire (US)Labs Are Vital(TM) Announces Winners of 2009 National Video Contest to Highlight Careers in Lab SciencesNYSE:ABT
15/07/200923h20Dow Jones NewsGeneric Drug Co Recalls Acetaminophen To Avoid Dose ConfusionNYSE:ABTAbbott Laboratories
15/07/200917h47Dow Jones News2nd UPDATE: Abbott Not Interested In Solvay's Tricor OperationsNYSE:ABTAbbott Laboratories
15/07/200917h03Dow Jones NewsUPDATE:Abbott Laboratories Not Bidding For Solvay Tricor OperationsNYSE:ABTAbbott Laboratories
15/07/200916h50Dow Jones NewsUPDATE: Abbott Labs 2Q Profit Down 2.6%, Gives Cautious ViewNYSE:ABTAbbott Laboratories
15/07/200916h40Dow Jones NewsUS EARNINGS WRAP: Abbott Profit Down, Gannett Back In BlackNYSE:ABTAbbott Laboratories
15/07/200916h28Dow Jones NewsAbbott Laboratories Not Bidding For Solvay's Tricor OperationsNYSE:ABTAbbott Laboratories
15/07/200915h05Dow Jones NewsAbbott Labs 2Q Profit Down 2.6%, Gives Cautious ViewNYSE:ABTAbbott Laboratories
14/07/200918h00Dow Jones News3rd UPDATE: J&J's 2Q Profit Down 3.6% On Forex, GenericsNYSE:ABTAbbott Laboratories
14/07/200916h33Dow Jones News2nd UPDATE: J&J 2Q Profit Down 3.6% On Forex, GenericsNYSE:ABTAbbott Laboratories
13/07/200920h07Dow Jones NewsAbbott, GSK To Develop Molecular Diagnostic TestNYSE:ABTAbbott Laboratories
10/07/200920h53Dow Jones NewsUS EQUITIES WEEK AHEAD: Banks, Tech Report; Sotomayor HearingNYSE:ABTAbbott Laboratories
08/07/200923h58Dow Jones News2nd UPDATE: Trial Of Cholesterol Drugs TerminatedNYSE:ABTAbbott Laboratories
08/07/200923h33Dow Jones NewsUPDATE: Trial Of Cholesterol Drugs TerminatedNYSE:ABTAbbott Laboratories
08/07/200922h53Dow Jones NewsTrial Of Abbott, Merck/Schering Cholesterol Drugs TerminatedNYSE:ABTAbbott Laboratories
08/07/200905h29Dow Jones NewsUPDATE: Kennedy Breaks With White House Over BiologicsNYSE:ABTAbbott Laboratories
08/07/200904h48Dow Jones NewsKennedy Breaks With White House Over BiologicsNYSE:ABTAbbott Laboratories
07/07/200922h55Dow Jones NewsUPDATE: Abbott Labs Names New Head Of Pharmaceutical UnitNYSE:ABTAbbott Laboratories
07/07/200918h09Dow Jones NewsAbbott Labs Names New Head Of Pharmaceutical UnitNYSE:ABTAbbott Laboratories
01/07/200916h55Dow Jones NewsAcura, King Could Benefit From FDA Panel Votes On Pain DrugsNYSE:ABTAbbott Laboratories
01/07/200901h00Dow Jones News3rd UPDATE: FDA Panel For Eliminating Some Acetaminophen ProductsNYSE:ABTAbbott Laboratories
30/06/200922h20Dow Jones News2nd UPDATE: FDA Panel For Eliminating Some Acetaminophen ProductsNYSE:ABTAbbott Laboratories
30/06/200917h41Dow Jones NewsReport: Cost Should Play Role In Comparing Medical TreatmentsNYSE:ABTAbbott Laboratories
23/06/200914h00PR Newswire (US)Abbott Receives CE Mark for Company's Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership PositionNYSE:ABT
19/06/200916h48Dow Jones NewsFDA Staff Recommends Updated Warning For AsmanexNYSE:ABTAbbott Laboratories
12/06/200916h50PR Newswire (US)Abbott Declares 342nd Consecutive Quarterly DividendNYSE:ABT
10/06/200918h11Dow Jones NewsAbbott CEO: No Interest In Large, 'Mega-Deal' MergersNYSE:ABTAbbott Laboratories
09/06/200919h09Dow Jones NewsSuccessful TriLipix Trials Good News For Solvay - AnalystsNYSE:ABTAbbott Laboratories
09/06/200917h30Dow Jones NewsIN THE PIPELINE: Less Is More In Boston Sci Stent PlansNYSE:ABTAbbott Laboratories
08/06/200900h41Dow Jones NewsCORRECT: Large Study Questions Value Of StentsNYSE:ABTAbbott Laboratories
 Showing the most relevant articles for your search:BIT:ABT

Dernières Valeurs Consultées

LSE
HWDC
Hsbc Msci Wl Ch
LSE
IAUS
Ishr Australia
NYSE
WFC-V
Wells Fargo
NASDAQ
ATXG
Addentax
BIT
1GME
Gamestop
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés